Literature DB >> 20143265

Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques.

Pablo Ortega-Deballon1, Olivier Facy, Sophie Jambet, Guy Magnin, Eddy Cotte, Jean L Beltramo, Bruno Chauffert, Patrick Rat.   

Abstract

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) achieves good results in selected patients with peritoneal carcinomatosis. There are two main procedures to deliver this therapy: the open abdomen and the closed abdomen techniques. A true comparison of the two techniques has never been performed. The aim of this study was to compare blood and abdominal tissue concentrations of oxaliplatin after open and closed techniques to deliver HIPEC.
METHODS: Nine pigs underwent HIPEC at 42-43 degrees C for 30 min with oxaliplatin (400 mg/m(2)) according to two techniques: closed (three animals) or open (six animals). The open technique used either an external heater with a pump (three animals) or an intra-abdominal heating cable (three animals) to achieve hyperthermia. Temperature homogeneity, systemic absorption, and abdominal tissue mapping of the penetration of oxaliplatin with each technique were studied. Two additional pigs underwent hyperthermia with dyes instead of oxaliplatin to depict the distribution of the liquid within the abdomen with both techniques.
RESULTS: Hyperthermia was satisfactory with both techniques. The closed technique achieved higher temperatures within the diaphragmatic area, while the open technique obtained higher temperatures in the mid and lower abdomen (P < 0.001 for both comparisons). The systemic absorption of oxaliplatin was higher with the open technique (P < 0.04 for all comparisons), as was the accumulation within the abdominal cavity. The operating time for the two techniques was not greatly different.
CONCLUSIONS: Intraperitoneal hyperthermia can be achieved with both techniques. The open technique had far higher systemic absorption and abdominal tissue penetration of oxaliplatin than the closed technique.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143265     DOI: 10.1245/s10434-010-0937-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

Review 1.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure.

Authors:  Loek A W de Jong; Fortuné M K Elekonawo; Philip R de Reuver; Andre J A Bremers; Johannes H W de Wilt; Frank G A Jansman; Rob Ter Heine; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

Review 2.  Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy.

Authors:  Aditi Bhatt; Sourabh Mittal; K S Gopinath
Journal:  Indian J Surg Oncol       Date:  2016-02-02

3.  Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy.

Authors:  S J Valle; N A Alzahrani; W Liauw; P H Sugarbaker; A Bhatt; D L Morris
Journal:  Indian J Surg Oncol       Date:  2016-02-05

Review 4.  Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer.

Authors:  Thomas Boerner; Oliver Zivanovic; Dennis S Chi
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 5.  Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review.

Authors:  Mikhail Yu Reutovich; Olga V Krasko; Oleg G Sukonko
Journal:  J Gastrointest Oncol       Date:  2021-04

6.  Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis.

Authors:  Terence C Chua; Winston Liauw; Jing Zhao; David L Morris
Journal:  Int J Clin Oncol       Date:  2012-03-14       Impact factor: 3.402

7.  Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis.

Authors:  Olivier Facy; François Radais; Sylvain Ladoire; Delphine Delroeux; Hervé Tixier; François Ghiringhelli; Patrick Rat; Bruno Chauffert; Pablo Ortega-Deballon
Journal:  J Exp Clin Cancer Res       Date:  2011-01-07

Review 8.  Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer.

Authors:  Aditi Bhatt; Diane Goéré
Journal:  Indian J Surg Oncol       Date:  2016-02-04

9.  Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer.

Authors:  Danilo Coco; Silvana Leanza
Journal:  Maedica (Buchar)       Date:  2019-09

Review 10.  Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Authors:  Seung Yoon Yang; Jae Hyun Kang; Ho Seung Kim; Yoon Dae Han; Byung Soh Min; Kang Young Lee
Journal:  J Gastrointest Oncol       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.